Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Mar 1;78(3):261-269.
doi: 10.1001/jamapsychiatry.2020.3650.

Sequential Combination of Pharmacotherapy and Psychotherapy in Major Depressive Disorder: A Systematic Review and Meta-analysis

Jenny Guidi  1 , Giovanni A Fava  2
Affiliations
Meta-Analysis

Sequential Combination of Pharmacotherapy and Psychotherapy in Major Depressive Disorder: A Systematic Review and Meta-analysis

Jenny Guidi et al. JAMA Psychiatry. .

Abstract

Importance: The sequential model emerged from the awareness that the persistence of residual symptoms and the frequent occurrence of psychiatric comorbidity were both associated with poor long-term outcome of major depressive disorder (MDD).

Objective: To conduct an updated meta-analysis to examine the association of the sequential combination of pharmacotherapy and psychotherapy with reduced risk of relapse and recurrence in MDD.

Data sources: Keyword searches were conducted in PubMed, PsycInfo, Web of Science, and the Cochrane Library from inception of each database through November 2019. Reference lists from relevant studies were examined using the following keywords: sequential treatment, drugs and psychotherapy, combined treatment, continuation or maintenance, relapse or recurrence and prevention, and depress* or major depress*, selecting adults and randomized controlled trials as additional limits. Authors of selected articles were contacted if needed.

Study selection: Randomized clinical trials examining the effectiveness of the sequential use of psychotherapy following response to acute-phase pharmacotherapy in the treatment of adult remitted patients with MDD were selected independently by 2 reviewers.

Data extraction and synthesis: The methods used fulfilled the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guideline. Data extraction and methodologic quality assessment were conducted independently by the reviewers. Examination of the pooled results was performed based on the random-effects model. Heterogeneity between study results and likelihood of significant publication bias were assessed. Sensitivity analyses and meta-regressions were also run.

Main outcomes and measures: The primary outcome measures were relapse or recurrence rates of MDD, as defined by study investigators, at the longest available follow-up.

Results: Seventeen randomized clinical trials met criteria for inclusion in the meta-analysis, with 1 study yielding 2 comparisons (2283 patients overall, with 1208 patients in a sequential treatment arm and 1075 in a control arm). The pooled risk ratio for relapse/recurrence of MDD was 0.84 (95% CI, 0.74-0.94), suggesting a relative advantage in preventing relapse/recurrence for the sequential combination of treatments compared with control conditions.

Conclusions and relevance: The results of this systematic review and meta-analysis indicate that the sequential integration of psychotherapy following response to acute-phase pharmacotherapy, alone or combined with antidepressant medication, was associated with reduced risk of relapse and recurrence in MDD. The preventive value of the sequential strategy relies on abatement of residual symptoms and/or increase in psychological well-being. The steps for implementing the sequential approach in remitted patients with recurrent MDD are provided.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Fava has written a book on well-being therapy, for which he receives no royalties. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Flowchart of Included Studies
ECT indicates electroconvulsive therapy; RCT, randomized clinical trial.
Figure 2.
Figure 2.. Sequential Combination of Pharmacotherapy and Psychotherapy Associated With Reduced Relapse/Recurrence Risk in Major Depressive Disorder
RR indicates risk ratio. aStudies involving drug discontinuation.
Figure 3.
Figure 3.. Steps for Implementing the Sequential Approach in Patients With Recurrent Depression
ADM indicates antidepressant medication; MBCT, mindfulness-based cognitive therapy; WBT, well-being therapy.
See this image and copyright information in PMC

References

    1. Fava GA. Sequential treatment: a new way of integrating pharmacotherapy and psychotherapy. Psychother Psychosom. 1999;68(5):227-229. doi:10.1159/000012338 - DOI - PubMed
    1. Kupfer DJ. Maintenance treatment in recurrent depression: current and future directions: the first William Sargant Lecture. Br J Psychiatry. 1992;161:309-316. doi:10.1192/bjp.161.3.309 - DOI - PubMed
    1. Demyttenaere K. What is treatment resistance in psychiatry? a “difficult to treat” concept. World Psychiatry. 2019;18(3):354-355. doi:10.1002/wps.20677 - DOI - PMC - PubMed
    1. Fava GA, Kellner R. Prodromal symptoms in affective disorders. Am J Psychiatry. 1991;148(7):823-830. doi:10.1176/ajp.148.7.823 - DOI - PubMed
    1. Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A. Residual symptoms after partial remission: an important outcome in depression. Psychol Med. 1995;25(6):1171-1180. doi:10.1017/S0033291700033146 - DOI - PubMed

MeSH terms

Substances